Elixir Medical Clinical Evaluation of the DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System - The DESolve Nx Trial

NCT02086045 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: DESolve Novolimus Eluting Bioresorbable Coronary Scaffold System

Sponsor

Elixir Medical Corporation